These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1017110)

  • 21. Some 10-substituted 5-ethyl-10-dialkylaminoalkyl-10,11-dihydro-5H-dibenz[b,f]azepines as potential antiarrhythmic agents.
    Ellefson CR; Cusic JW
    J Med Chem; 1976 Nov; 19(11):1345-9. PubMed ID: 1003416
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparative effects of three class I antiarrhythmic drugs on plateau and pacemaker currents of sheep cardiac Purkinje fibres.
    Coraboeuf E; Deroubaix E; Escande D; Coulombe A
    Cardiovasc Res; 1988 Jun; 22(6):375-84. PubMed ID: 2852055
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protein binding and erythrocyte partitioning of disopyramide and its monodealkylated metabolite.
    Hinderling PH; Bres J; Garrett ER
    J Pharm Sci; 1974 Nov; 63(11):1684-90. PubMed ID: 4427225
    [No Abstract]   [Full Text] [Related]  

  • 24. Transient increase in the contractile force induced by antiarrhythmic drugs in guinea pig cardiac muscles.
    Nawada T; Hasegawa J; Noguchi N; Hirokane Y; Kotake H; Mashiba H
    Am J Cardiol; 1989 May; 63(15):1144-6. PubMed ID: 2495711
    [No Abstract]   [Full Text] [Related]  

  • 25. Binding profiles of class I antiarrhythmic agents to cardiac muscarinic receptors: competitive and allosteric interactions with the receptors and their pharmacological significance.
    Endou M; Gando S; Hattori Y; Kanno M
    J Pharmacol Exp Ther; 1991 Sep; 258(3):992-8. PubMed ID: 1890628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of disopyramide in comparison with verapamil and propranolol in the prevention of acetylcholine-induced atrial fibrillation in the dog.
    Bertrix L; Timour Chah Q; Lang J; Lakhal M; Bouzouita K; Faucon G
    Arch Int Pharmacodyn Ther; 1985 Mar; 274(1):97-110. PubMed ID: 4015264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effect of disopyramide phosphate in extrasystole at rest and on exercise (author's transl)].
    Stauch M; Grewe N; Nissen H
    MMW Munch Med Wochenschr; 1976 Mar; 118(11):331-4. PubMed ID: 57570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pharmacology of Norpace.
    Dean RR
    Angiology; 1975 Jan; 26(1 Pt 2):67-84. PubMed ID: 1115403
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparative effect of imolamine, lidocaine and disopyramide on experimental rhythm disorders and auriculoventricular conduction.
    Junien JL; Lakatos CR; Tine J
    Arzneimittelforschung; 1974 Nov; 24(11):1743-7. PubMed ID: 4141258
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of 4 antiarrhythmic drugs on sinoatrial conduction time in isolated and blood-perfused dog atria.
    Shimotori M; Kobayashi M; Chiba S
    Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):67-79. PubMed ID: 6721625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined effect of disopyramide and bethanechol: use of bethanechol to prevent anticholinergic side effects of disopyramide without reduction of antiarrhythmic efficacy.
    Konishi T; Kadoya M; Ikeguchi S; Sakai K; Tamamura T; Kawai C
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):341-50. PubMed ID: 2476611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Electrophysiological effects of the antiarrhythmia agents disopyramide and propafenone on human heart conduction system].
    Seipel L; Breithardt G; Both A
    Z Kardiol; 1975 Aug; 64(8):731-40. PubMed ID: 1163095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Proceedings: Anti-arrhythmic action of disopyramide].
    Nakamura T; Takahashi K; Niitani U; Sugiura T; Miyaji K
    Jpn Circ J; 1975 Apr; 39(4):497. PubMed ID: 1121090
    [No Abstract]   [Full Text] [Related]  

  • 34. [Comparison of the effects of disopyramide and hydroquinidine in animals].
    Lisin N; Carlier J
    Arch Mal Coeur Vaiss; 1973 Oct; 66(10):1329-35. PubMed ID: 4207476
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity.
    Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A
    J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the novel class Ia and class III antiarrhythmic agent RS-87337 on myocardial conduction in the anaesthetised dog.
    Allely MC; Alps BJ
    Arch Int Pharmacodyn Ther; 1988; 295():138-46. PubMed ID: 3245729
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The electrophysiological effects of disopyramide (author's transl)].
    Ponsonnaille J; Marcheix JC; Gras H
    Ann Cardiol Angeiol (Paris); 1977; 26(2):135-9. PubMed ID: 900834
    [No Abstract]   [Full Text] [Related]  

  • 38. Anti-arrhythmic and haemodynamic effects of intravenous and oral disopyramide in patients with ventricular arrhythmia.
    Hulting J; Rosenhamer G
    J Int Med Res; 1976; 4(1 Suppl):90-5. PubMed ID: 1026537
    [No Abstract]   [Full Text] [Related]  

  • 39. Disopyramide--a new antiarrhythmic agent.
    Chow M
    Conn Med; 1978 Apr; 42(4):233-4. PubMed ID: 639508
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of disopyramide on the sino-atrial node].
    Garcia BD; Perez T; Nieto LK
    Kardiologiia; 1976 Mar; 16(3):134-5. PubMed ID: 1021623
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.